Revance Therapeutics, Inc. is a privately held specialty biopharmaceutical company dedicated to developing the next generation of innovative products in dermatology and aesthetic medicine.

Revance has developed the proprietary TransMTS™ technology which allows large macromolecules to cross skin and other barrier membranes enabling local, targeted delivery. This technology will change the way that drugs are delivered; allowing skin to be a gateway for drug delivery rather than a barrier.